The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a ‘mitohormesis’ mechanism involving reactive oxygen species and PGC-1
Open accessAbstract
AIMS: Statins protect against cardiovascular-related mortality but induce skeletal muscle toxicity. To investigate mechanisms of statins, we tested the hypothesis that statins optimized cardiac mitochondrial function but impaired vulnerable skeletal muscle by inducing different level of reactive oxygen species (ROS). METHODS AND RESULTS: In atrium of patients treated with statins, ROS production was decreased and oxidative capacities were enhanced together with an extensive augmentation of mRNAs expression of peroxisome proliferator-activated receptor gamma co-activator (PGC-1) family. However, in deltoid biopsies from patients with statin-induced muscular myopathy, oxidative capacities were decreased together with ROS increase and a collapse of PGC-1 mRNA expression. Several animal and cell culture experiments were conducted and showed by using ROS scavengers that ROS production was the triggering factor responsible of atorvastatin-induced activation of mitochondrial biogenesis pathway and improvement of antioxidant capacities in heart. Conversely, in skeletal muscle, the large augmentation of ROS production following treatment induced mitochondrial impairments, and reduced mitochondrial biogenesis mechanisms. Quercetin, an antioxidant molecule, was able to counteract skeletal muscle deleterious effects of atorvastatin in rat. CONCLUSION: Our findings identify statins as a new activating factor of cardiac mitochondrial biogenesis and antioxidant capacities, and suggest the importance of ROS/PGC-1 signalling pathway as a key element in regulation of mitochondrial function in cardiac as well as skeletal muscles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“other studies have shown increased ROS production (3,42) and a decreased antioxidant capacity (3) with statin treatment.”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [3]
In the citing paper
“Our findings of significantly reduced antioxidant capacity in combination with the known (3,40) elevated ROS production in the simvastatin-treated patients make it plausible that increased apoptosis could contribute to muscle pain in patients treated with statins.”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Schulz, T. J., Zarse, K., Voigt, A., Urban, N., Birringer, M., & Ristow, M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.011 · Cited by 1,209
Transcriptional control of mitochondrial biogenesis: the central role of PGC-1
Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn098 · Cited by 932
Cerivastatin and Reports of Fatal Rhabdomyolysis
Staffa, J. A., Chang, J. T., & Green, L. (2002) · New England Journal of Medicine · doi:10.1056/nejm200202143460721 · Cited by 627
Piantadosi, C. A., Carraway, M. S., Babiker, A., & Suliman, H. B. (2008) · Circulation Research · doi:10.1161/01.res.0000338597.71702.ad · Cited by 581
Statin effects beyond lipid lowering—are they clinically relevant?
Bonetti, P. O. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00419-0 · Cited by 526
Stress-Response Hormesis and Aging: “That which Does Not Kill Us Makes Us Stronger”
Gems, D., & Partridge, L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.01.001 · Cited by 496
Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1α expression.
Wright, D. C., Han, D.-H., Garcia-Roves, P. M., Geiger, P. C., Jones, T. E., & Holloszy, J. O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606116200 · Cited by 488
Mitochondrial H + Leak and ROS Generation: An Odd Couple
Brookes, P. S. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.016 · Cited by 447
Lelliott, C. J., Medina-Gomez, G., Petrovic, N., Kis, A., Feldmann, H. M., Bjursell, M., Parker, N., Curtis, K., Campbell, M., Hu, P., et al. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040369 · Cited by 280
Cited by
Sorted by citations
Pleiotropic Effects of Statins on the Cardiovascular System
Oesterle, A., Laufs, U., & Liao, J. K. (2017) · Circulation Research · doi:10.1161/circresaha.116.308537 · Cited by 1,247
García-Sánchez, A., Miranda‐Díaz, A. G., & Cardona-Muñóz, E. G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2082145 · Cited by 369
Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
Chen, X. '., Stewart, E. A., Shelat, A. A., Qu, C., Bahrami, A., Hatley, M. E., Wu, G., Bradley, C. L., McEvoy, J. D., Pappo, A. S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.002 · Cited by 295
Effects of statins on mitochondrial pathways
Mollazadeh, H., Tavana, E., Fanni, G., Bo, S., Banach, M., Pirro, M., von Haehling, S., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12654 · Cited by 270
Simvastatin Impairs Exercise Training Adaptations
Mikus, C. R., Boyle, L. J., Borengasser, S. J., Oberlin, D. J., Naples, S. P., Fletcher, J. A., Meers, G. M.-E., Ruebel, M. L., Laughlin, M. H., Dellsperger, K. C., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.074 · Cited by 249
Local hyperthermia therapy induces browning of white fat and treats obesity
Li, Y., Wang, D., Ping, X., Zhang, Y., Zhang, T., Wang, L., Li, J., Zhao, W., Guo, M., Shen, F., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.004 · Cited by 224
MitoTimer: A novel tool for monitoring mitochondrial turnover
Hernandez, G., Thornton, C., Stotland, A., Lui, D., Sin, J., Ramil, J., Magee, N., Andres, A., Quarato, G., Carreira, R. S., et al. (2013) · Autophagy · doi:10.4161/auto.26501 · Cited by 187
Pleiotropic effects of statins
Vasnawala, H., Kavalipati, N., Shah, J., & Ramakrishan, A. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.163106 · Cited by 189
Emerging role of mitophagy in cardiovascular physiology and pathology
Morales, P. E., Arias-Durán, C., Ávalos-Guajardo, Y., Aedo, G., Verdejo, H., Parra, V., & Lavandero, S. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.09.006 · Cited by 179
Intolerance to Statins: Mechanisms and Management
Bitzur, R., Cohen, H., Kamari, Y., & Harats, D. (2013) · Diabetes Care · doi:10.2337/dcs13-2038 · Cited by 185
Gomez-Cabrera, M. C., Salvador-Pascual, A., Cabo, H., Ferrando, B., & Viña, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.006 · Cited by 172
Sandhir, R., & Mehrotra, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.018 · Cited by 171
Statins: Adverse reactions, oxidative stress and metabolic interactions
Liu, A., Wu, Q., Guo, J., Arés, I., Rodríguez, J.-L., Martínez‐Larrañaga, M., Yuan, Z., Anadón, A., Wang, X., & Martínez, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.004 · Cited by 168
Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease
Zhang, Z., Dalan, R., Hu, Z., Wang, J., Chew, N., Poh, K. K., Tan, R., Soong, T. W., Dai, Y., Ye, L., et al. (2022) · Advanced Materials · doi:10.1002/adma.202202169 · Cited by 174
Simvastatin Effects on Skeletal Muscle
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Bang, L. E., Bundgaard, H., Nielsen, L. B., Helge, J. W., & Dela, F. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.036 · Cited by 165
Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases
Mansouri, A., Reiner, Ž., Ruscica, M., Tedeschi-Reiner, E., Radbakhsh, S., Ekta, M. B., & Sahebkar, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051313 · Cited by 173
Myotoxicity of statins: Mechanism of action
du Souich, P., Roederer, G. O., & Dufour, R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.029 · Cited by 168
Mitochondria in vascular disease
Yu, E., Mercer, J. R., & Bennett, M. R. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs111 · Cited by 153
Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion
Paradis, S., Charles, A., Meyer, A., Lejay, A., Scholey, J. W., Chakfé, N., Zoll, J., & Gény, B. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00356.2015 · Cited by 148
Mechanisms of statin-associated skeletal muscle-associated symptoms
Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Singh, F., & Krähenbühl, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.010 · Cited by 152
The role of mitochondria in statin‐induced myopathy
Apostolopoulou, M., Corsini, A., & Roden, M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12461 · Cited by 142
Statins and Pulmonary Fibrosis: The Potential Role of NLRP3 Inflammasome Activation
Xu, J., Washko, G. R., Nakahira, K., Hatabu, H., Patel, A. S., Fernandez, I. E., Nishino, M., Okajima, Y., Yamashiro, T., Ross, J. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1574oc · Cited by 140
Gouni‐Berthold, I., Berthold, H. K., Huh, J. Y., Berman, R., Spenrath, N., Krone, W., & Mantzoros, C. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072858 · Cited by 134
Dott, W., Mistry, P., WRIGHT, J. A., Cain, K., & Herbert, K. E. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.028 · Cited by 127
Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT/GPx4 Axis
Zhang, Q., Qu, H., Chen, Y., Luo, X., Chen, C., Xiao, B., Ding, X., Zhao, P., Lu, Y., Chen, A. F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.806081 · Cited by 119
A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy
Whitehead, N. P., Kim, M. J., Bible, K. L., Adams, M. E., & Froehner, S. C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509536112 · Cited by 110
Mechanisms of Hepatocellular Toxicity Associated with Dronedarone—A Comparison to Amiodarone
Felser, A., Blum, K., Lindinger, P. W., Bouitbir, J., & Krähenbühl, S. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs298 · Cited by 109
Li, X., Wang, H., Gao, Y., Li, L., Tang, C., Wen, G., Zhou, Y., Zhou, M., Mao, L., & Fan, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164237 · Cited by 109
Reductive stress impairs myoblasts mitochondrial function and triggers mitochondrial hormesis
Singh, F., Charles, A., Schlagowski, A.-I., Bouitbir, J., Bonifacio, A., Piquard, F., Krähenbühl, S., Gény, B., & Zoll, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.03.006 · Cited by 105
Role of PGC-1α in Vascular Regulation
Kadlec, A. O., Chabowski, D. S., Ait‐Aissa, K., & Gutterman, D. D. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307123 · Cited by 103
Statins, Muscle Disease and Mitochondria
Ramachandran, R., & Wierzbicki, A. S. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6080075 · Cited by 91
The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity
Bonifacio, A., Sanvee, G. M., Bouitbir, J., & Krähenbühl, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.010 · Cited by 93
Bouitbir, J., Singh, F., Charles, A., Schlagowski, A.-I., Bonifacio, A., Echaniz‐Laguna, A., Gény, B., Krähenbühl, S., & Zoll, J. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6190 · Cited by 100
Human Skeletal Muscle Mitochondrial Adaptations Following Resistance Exercise Training
Parry, H. A., Roberts, M. D., & Kavazis, A. N. (2020) · International Journal of Sports Medicine · doi:10.1055/a-1121-7851 · Cited by 99
Pharmacological Strategies to Retard Cardiovascular Aging
Alfaras, I., Germanio, C. D., Bernier, M., Csiszár, A., Ungvari, Z. I., Lakatta, E. G., & de Cabo, R. (2016) · Circulation Research · doi:10.1161/circresaha.116.307475 · Cited by 87
Rasmussen, S. T., Andersen, J. T., Nielsen, T. K., Cejvanovic, V., Petersen, K. M., Henriksen, T., Weimann, A., Lykkesfeldt, J., & Poulsen, H. E. (2016) · Redox Biology · doi:10.1016/j.redox.2016.05.007 · Cited by 85
Muntean, D. M., Thompson, P. D., Catapano, A. L., Stasiolek, M., Fabis, J., Muntner, P., Serban, M.-C., & Banach, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.001 · Cited by 82
New and revisited approaches to preserving the reperfused myocardium
Kloner, R. A., Brown, D. A., CSETE, M. E., Dai, W., Downey, J. M., Gottlieb, R. A., Hale, S. L., & Shi, J. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.102 · Cited by 86
Wu, F., Li, Z., Cai, M., Xi, Y., Xu, Z., Zhang, Z., Li, H., Zhu, W., & Tian, Z. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.038 · Cited by 82
Mitochondrial Function and Dysfunction: An Update
Davis, R. E., & Williams, M. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192104 · Cited by 91
Bland, A. R., Payne, F. M., Ashton, J. C., Jamialahmadi, T., & Sahebkar, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105986 · Cited by 82
Drug induced mitochondrial dysfunction: Mechanisms and adverse clinical consequences
Vuda, M., & Kamath, A. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.10.005 · Cited by 83
Meyer, A., Zoll, J., Charles, A. L., Charloux, A., de Blay, F., Diemunsch, P., Sibilia, J., Piquard, F., & Geny, B. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.069468 · Cited by 90
Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy
Stringer, H. A. J., Sohi, G. K., Maguire, J. A., & Côté, H. C. F. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.12.023 · Cited by 79
Urbano, F., Bugliani, M., Filippello, A., Scamporrino, A., Mauro, S. D., Pino, A. D., Scicali, R., Noto, D., Rabuazzo, A. M., Averna, M. R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11070-x · Cited by 79
Molecular mechanisms of statin intolerance
Gluba-Brzózka, A., Franczyk, B., Toth, P. P., Rysz, J., & Banach, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59938 · Cited by 73
Atherosclerosis and the Capillary Network; Pathophysiology and Potential Therapeutic Strategies
Ziegler, T., Rahman, F. A., Jurisch, V., & Kupatt, C. (2019) · Cells · doi:10.3390/cells9010050 · Cited by 80
Pal, S., Ghosh, M., Ghosh, S., Bhattacharyya, S., & Sil, P. C. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.05.016 · Cited by 72
Aging Fits the Disease Criteria of the International Classification of Diseases
Khaltourina, D. A., Matveyev, Y., Alekseev, A., Cortese, F., & Ioviţă, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111230 · Cited by 78
Mitochondrial oxidative stress plays a critical role in the cardiotoxicity of sunitinib
Bouitbir, J., Alshaikhali, A., Panajatovic, M. V., Abegg, V. F., Paech, F., & Krähenbühl, S. (2019) · Toxicology · doi:10.1016/j.tox.2019.152281 · Cited by 68
Statins and skeletal muscles toxicity: From clinical trials to everyday practice
Norata, G. D., Tibolla, G., & Catapano, A. L. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.012 · Cited by 66
Bonifacio, A., Mullen, P. J., Mityko, I. S., Navegantes, L. C. C., Bouitbir, J., & Krähenbühl, S. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1378-4 · Cited by 61
Charles, A., Guilbert, A.-S., Guillot, M., Talha, S., Lejay, A., Meyer, A., Kindo, M. J., Wolff, V., Bouitbir, J., Zoll, J., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00052 · Cited by 62
Vaughan, R. A., Garcia-Smith, R., Bisoffi, M., Conn, C. A., & Trujillo, K. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.009 · Cited by 58
Ahmed, L. A., Darwish, H. A., Abdelsalam, R. M., & Amin, H. A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9303-2 · Cited by 55
Mansour, Z., Bouitbir, J., Charles, A. L., Talha, S., Kindo, M. J., Pottecher, J., Zoll, J., & Gény, B. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.07.084 · Cited by 55
Marcheggiani, F., Cirilli, I., Orlando, P., Silvestri, S., Vogelsang, A., Knott, A., Blatt, T., Weise, J. M., & Tiano, L. (2019) · Aging · doi:10.18632/aging.101926 · Cited by 53
A Mechanism for Statin-Induced Susceptibility to Myopathy
Lotteau, S. J., Ivarsson, N., Yang, Z., Restagno, D., Colyer, J., Hopkins, P. M., Weightman, A., Himori, K., Yamada, T., Bruton, J. D., et al. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.03.012 · Cited by 57
Charles, A., Meyer, A., Dal-Ros, S., Auger, C., Keller, N., Ramamoorthy, T. G., Zoll, J., METZGER, D., Schini‐Kerth, V. B., & Gény, B. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.067496 · Cited by 54
Enache, I., Charles, A., Bouitbir, J., Favret, F., Zoll, J., METZGER, D., Oswald–Mammosser, M., Gény, B., & Charloux, A. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1485-6 · Cited by 53
Egom, E. E. A., & Hafeez, H. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.10.005 · Cited by 57
Li, F., Wang, X., Deng, Z.-K., Zhang, X., Gao, P., & Liu, H. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.10.004 · Cited by 54
Mitochondrial Dysfunction, Oxidative Stress and Diabetic Cardiovascular Disorders
Shen, G. X. (2012) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x11202020106 · Cited by 50
Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma
Fanzani, A., & Poli, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081718 · Cited by 50
Targeting of stress response pathways in the prevention and treatment of cancer
Zelenka, J., Koncošová, M., & Ruml, T. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.007 · Cited by 50
Heart failure with preserved ejection fraction: Defining the function of ROS and NO
Zuo, L., Chuang, C., Hemmelgarn, B. T., & Best, T. M. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01149.2014 · Cited by 49
Mitochondria of trained skeletal muscle are protected from deleterious effects of statins
Bouitbir, J., Daussin, F., Charles, A., Rasseneur, L., Dufour, S. P., Richard, R., Piquard, F., Gény, B., & Zoll, J. (2012) · Muscle & Nerve · doi:10.1002/mus.23309 · Cited by 46
Guardia, P. G. L., Alberici, L. C., Ravagnani, F. G., Catharino, R. R., & Vercesi, A. E. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00103 · Cited by 46
Mechanisms of hepatotoxicity associated with the monocyclic β-lactam antibiotic BAL30072
Paech, F., Messner, S., Spickermann, J., Wind, M., Schmitt-Hoffmann, A.-H., Witschi, A. T., Howell, B. A., Church, R. J., Woodhead, J., Engelhardt, M. F., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1994-x · Cited by 45
The effects of statins on exercise and physical activity
Noyes, A. M., & Thompson, P. D. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.07.003 · Cited by 44
Cao, L., Li, Y. S., Smirnov, A., Voshtani, R., Wang, T., Shao, C., Candi, E., Melino, G., Shi, Y., & Fang, J. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01519-2 · Cited by 52
Dohlmann, T. L., Morville, T. H., Kuhlman, A. B., Chrøis, K. M., Helge, J. W., Dela, F., & Larsen, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01185 · Cited by 44
Mechanisms of simvastatin myotoxicity: The role of autophagy flux inhibition
Emami, A., Shojaei, S., Rosa, S. C. D. S., Aghaei, M., Samiei, E., Vosoughi, A. R., Kalantari, F., Kawalec, P., Thliveris, J. A., Sharma, P. K., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172616 · Cited by 42
Pal, S., Sarkar, A., Pal, P. B., & Sil, P. C. (2015) · Biochimie · doi:10.1016/j.biochi.2015.02.016 · Cited by 40
Wang, L., Zhang, X., Chan, J. Y., Shan, L., Cui, G., Cui, Q., Wang, Y., Li, J., Chen, H., Zhang, Q., et al. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25253 · Cited by 38
Vilne, B., Skogsberg, J., Asl, H. F., Talukdar, H. A., Kessler, T., Björkegren, J., & Schunkert, H. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.019 · Cited by 36
Goodman, C. A., Derk, P., Zacharewicz, E., Lee, R. S., Snow, R. J., Russell, A. P., & McConell, G. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128398 · Cited by 35
Baratli, Y., Charles, A., Wolff, V., Tahar, L. B., Smiri, L. S., Bouitbir, J., Zoll, J., Piquard, F., Tebourbi, O., Sakly, M., et al. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.09.006 · Cited by 35
Kindo, M. J., Gerelli, S., Bouitbir, J., Charles, A., Zoll, J., Minh, T. H., Monassier, L., Favret, F., Piquard, F., & Gény, B. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00332 · Cited by 35
Vaughan, R. A., Mermier, C. M., Bisoffi, M., Trujillo, K. A., & Conn, C. A. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0301-4 · Cited by 34
Guo, Z., Tian, Y., Liu, N., Chen, Y., Chen, X., Yuan, G., Chang, A., Chang, X., Wu, J., & Zhou, H. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.99359 · Cited by 34
Malboosi, N., Nasehi, M., Hashemi, M., Vaseghi, S., & Zarrindast, M. (2020) · Gene · doi:10.1016/j.gene.2020.144601 · Cited by 35
Maarman, G. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-63245-2_10 · Cited by 33
Bennett, N. K., Lee, M., Orr, A. L., & Nakamura, K. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307904121 · Cited by 32
The Effects of Statin Medications on Aerobic Exercise Capacity and Training Adaptations
Murlasits, Z., & Radak, Z. O. (2014) · Sports Medicine · doi:10.1007/s40279-014-0224-4 · Cited by 32
IGF-1 prevents simvastatin-induced myotoxicity in C2C12 myotubes
Bonifacio, A., Sanvee, G. M., Brecht, K., Kratschmar, D. V., Odermatt, A., Bouitbir, J., & Krähenbühl, S. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1871-z · Cited by 31
Fernandes, M., Patel, A., & Husi, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207371 · Cited by 32
Dohlmann, T. L., Kuhlman, A. B., Morville, T., Dahl, M., Asping, M., Orlando, P., Silvestri, S., Tiano, L., Helge, J. W., Dela, F., et al. (2022) · Antioxidants · doi:10.3390/antiox11091698 · Cited by 31
Nasehi, M., Torabinejad, S., Hashemi, M., Vaseghi, S., & Zarrindast, M. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00508-y · Cited by 30
Pathogenic Implications of Human Mitochondrial Aminoacyl-tRNA Synthetases
Schwenzer, H., Zoll, J., Florentz, C., & Sissler, M. (2013) · Topics in current chemistry · doi:10.1007/128_2013_457 · Cited by 30
Shi, Z., & Han, S. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41629 · Cited by 37
The mitohormetic response as part of the cytoprotection mechanism of berberine
Zhu, X., Wei, Y., Yang, B., Yin, X., & Guo, X. (2020) · Molecular Medicine · doi:10.1186/s10020-020-0136-8 · Cited by 29
Effects of statins on myocarditis: A review of underlying molecular mechanisms
Parsamanesh, N., Karami‐Zarandi, M., Banach, M., Penson, P. E., & Sahebkar, A. (2021) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2021.02.008 · Cited by 28
Implication of Lipids in Calcified Aortic Valve Pathogenesis: Why Did Statins Fail?
Nsaibia, M. J., Devendran, A. S., Goubaa, E., Bouitbir, J., Capoulade, R., & Bouchareb, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123331 · Cited by 24
Feng, H., Wang, J., Zheng, M., Zhang, C., An, Y., Li, L., & Wu, L. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.02.001 · Cited by 26
CYP2J2 Expression in Adult Ventricular Myocytes Protects Against Reactive Oxygen Species Toxicity
Evangelista, E. A., Lemaître, R. N., Sotoodehnia, N., Gharib, S. A., & Totah, R. A. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078840 · Cited by 27
Katsiki, N., Mikhailidis, D. P., Bajraktari, G., Miserez, A. R., Cicero, A. F. G., Bruckert, É., Șerban, M.-C., Mirrakhimov, E. M., Alnouri, F., Reiner, Ž., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104719 · Cited by 27
Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- Mice
Wu, W., Zhao, L., Yang, P., Zhou, W., Li, B., Moorhead, J. F., Varghese, Z., Ruan, X. Z., & Chen, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159512 · Cited by 25
Ren, L., Xuan, L., Han, F., Zhang, J., Gong, L., Lv, Y., Zhang, W., Yang, S. T., Xu, B., Yan, Y., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115076 · Cited by 25
Pleiotropic Benefits of Statins in Cardiovascular Diseases
Wasim, R., Ansari, T. M., Ahsan, F., Siddiqui, M. H., Singh, A., Shariq, M., & Parveen, S. (2022) · Drug Research · doi:10.1055/a-1873-1978 · Cited by 25
Metadata
- Authors
- Bouitbir, J., Charles, A.-L., Echaniz-Laguna, A., Kindo, M., Daussin, F., Auwerx, J., Piquard, F., Geny, B., & Zoll, J.
- Affiliations
- Hôpital Civil, Strasbourg (FR)
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Zoll, Joffrey
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-07-20
- Volume
- 33
- Issue
- 11
- Pages
- 1397-1407
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- PMC
- PMC3365271
- OpenAlex
- W2102743559
- Cited by
- 256
- References
- 30
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 13 · 2023: 14 · 2022: 18 · 2021: 12 · 2020: 24 · 2019: 22 · 2018: 18 · 2017: 22 · 2016: 25 · 2015: 18 · 2014: 9 · 2013: 17 · 2012: 16
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- HAL (submittedVersion)
- edoc (University of Basel) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- National Science Foundation
- Institut National de la Santé et de la Recherche Médicale
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-59820, P01DK059820)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- statins, atorvastatin, statin-induced myopathy, heart mitochondria, skeletal muscle mitochondria, reactive oxygen species, PGC-1, mitochondrial biogenesis, oxidative stress, antioxidant capacity, quercetin, mitohormesis, cardioprotection
- MeSH terms
- Atorvastatin, Animals, Antioxidants, Heart Atria, Heptanoic Acids, Humans, Male, Mitochondria, Heart, Mitochondria, Muscle, Pyrroles, Quercetin, RNA, Messenger, Superoxide Dismutase, Transcription Factors, Rats, Wistar, Reactive Oxygen Species, Muscle, Skeletal, Muscle Fibers, Skeletal, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Myocytes, Cardiac, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
